Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Sarcoma 40Neoplasm Metastasis 7Leiomyosarcoma 7Liposarcoma 6Hemangiosarcoma 6Neurofibrosarcoma 5Sarcoma, Synovial 4Osteosarcoma 4Histiocytoma, Malignant Fibrous 4Glioblastoma 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Sarcoma, Alveolar Soft Part 3Neoplasms 3Gliosarcoma 3Gastrointestinal Stromal Tumors 3Fibrosarcoma 3Breast Neoplasms 3Brain Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Recurrence 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nerve Sheath Neoplasms 2Histiocytoma, Angiomatoid Fibrous 2Hemangioendothelioma, Epithelioid 2Granuloma, Plasma Cell 2Carcinoma, Renal Cell 2

Interventions

Filgrastim 4Carboplatin 4Thiotepa 3pembrolizumab 2ixabepilone 2Temozolomide 2Riluzole 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Melphalan 2Ipilimumab 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Drug Therapy 2Cyclophosphamide 2Busulfan 2trastuzumab deruxtecan 1spartalizumab 1sodium thiosulfate 1sargramostim 1pazopanib 1fludarabine 1etoposide phosphate 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × pazopanib × Sarcoma × Clear all
NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
31 enrolled 12 charts
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡